Cindy Motz
Stock Analyst at Goldman Sachs
(n/a)
# 4,499
Out of 4,886 analysts
14
Total ratings
8.33%
Success rate
-30%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cindy Motz
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
HQY HealthEquity | Upgrades: Neutral | $64 → $77 | $101.85 | -24.40% | 3 | Oct 21, 2022 | |
HCAT Health Catalyst | Maintains: Buy | $29 → $18 | $3.95 | +355.70% | 5 | Aug 10, 2022 | |
DOCS Doximity | Maintains: Buy | $53 → $46 | $60.86 | -24.42% | 3 | Aug 8, 2022 | |
TDOC Teladoc Health | Downgrades: Neutral | $55 → $36 | $8.07 | +346.10% | 3 | Jul 28, 2022 |
HealthEquity
Oct 21, 2022
Upgrades: Neutral
Price Target: $64 → $77
Current: $101.85
Upside: -24.40%
Health Catalyst
Aug 10, 2022
Maintains: Buy
Price Target: $29 → $18
Current: $3.95
Upside: +355.70%
Doximity
Aug 8, 2022
Maintains: Buy
Price Target: $53 → $46
Current: $60.86
Upside: -24.42%
Teladoc Health
Jul 28, 2022
Downgrades: Neutral
Price Target: $55 → $36
Current: $8.07
Upside: +346.10%